Income Tax Expense (Benefit) in USD of Citius Pharmaceuticals, Inc. from Q4 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q4 2010 to Q2 2025.
  • Citius Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2025 was $264K.
  • Citius Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2024 was $576K.
  • Citius Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $576K.
  • Citius Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $576K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Citius Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $264K* +$120K 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $264K* +$120K 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $264K* +$120K 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025
Q2 2024 $144K $0 0% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 $144K $0 0% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $144K $0 0% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025
Q2 2023 $144K 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $144K 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $144K 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024
Q3 2021 $1.23K -$1 01 Jul 2021 30 Sep 2021 10-K 15 Dec 2021
Q2 2021 $423 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $406 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $405 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022
Q2 2014 $0 $0 $0 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2014
Q1 2014 $0 $0 $0 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014
Q4 2013 $0 $0 $0 01 Oct 2013 31 Dec 2013 10-Q 19 Feb 2014
Q3 2013 $0 $0 $0 01 Jul 2013 30 Sep 2013 10-K 06 Feb 2014
Q2 2013 $0 $0 $0 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 $0 $0 $0 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 $0 $0 $0 01 Oct 2012 31 Dec 2012 10-Q 19 Feb 2014
Q3 2012 $0 $0 $0 01 Jul 2012 30 Sep 2012 10-K 06 Feb 2014
Q2 2012 $0 $0 $0 01 Apr 2012 30 Jun 2012 10-Q 18 Sep 2013
Q1 2012 $0 $0 $0 01 Jan 2012 31 Mar 2012 10-Q 13 May 2013
Q4 2011 $0 $0 $0 01 Oct 2011 31 Dec 2011 10-Q 08 Feb 2013
Q3 2011 $0 $0 01 Jul 2011 30 Sep 2011 10-K 15 Jan 2013
Q2 2011 $0 01 Apr 2011 30 Jun 2011 10-Q 17 Aug 2012
Q1 2011 $0 01 Jan 2011 31 Mar 2011 10-Q 11 May 2012
Q4 2010 $0 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012

Citius Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $576K* $0 01 Oct 2023 30 Sep 2024 10-K 27 Dec 2024
2023 $576K* $0 01 Oct 2022 30 Sep 2023 10-K 27 Dec 2024
2022 $576K* +$575K 01 Oct 2021 30 Sep 2022 10-K 29 Dec 2023
2021 $1.23K +$492 +66.4% 01 Oct 2020 30 Sep 2021 10-K 15 Dec 2021
2020 $741 01 Oct 2019 30 Sep 2020 10-K 15 Dec 2021
2013 $0 $0 01 Oct 2012 30 Sep 2013 10-K 06 Feb 2014
2012 $0 $0 01 Oct 2011 30 Sep 2012 10-K 06 Feb 2014
2011 $0 01 Oct 2010 30 Sep 2011 10-K 15 Jan 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.